{
    "table_name": "PANCANCER_ATLAS_FILTERED.PURITY_PLOIDY_ALL_SAMPLES_FILTERED",
    "table_fullname": "PANCANCER_ATLAS_1.PANCANCER_ATLAS_FILTERED.PURITY_PLOIDY_ALL_SAMPLES_FILTERED",
    "column_names": [
        "Purity",
        "Study",
        "Cancer_DNA_fraction",
        "CallStatus",
        "SampleBarcode",
        "ParticipantBarcode",
        "SampleTypeLetterCode",
        "Subclonal_genome_fraction",
        "Genome_doublings",
        "Ploidy",
        "Solution",
        "SampleType",
        "AliquotBarcode",
        "Coverage_for_80_power"
    ],
    "column_types": [
        "FLOAT",
        "TEXT",
        "FLOAT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "FLOAT",
        "FLOAT",
        "FLOAT",
        "TEXT",
        "TEXT",
        "TEXT",
        "FLOAT"
    ],
    "description": [
        "Purity estimates; values betwen 0 and 1 representing the fraction of cancer cells in a solid tumor sample",
        "TCGA study abbreviation, eg LAML. Full list available at https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations",
        "Cancer DNA fractions; more information available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383288/",
        "Either 'called' or NULL indicating if data data were analyzed or not, respectively",
        "Barcode of the biospecimen sample, eg TCGA-13-1489-02A",
        "TCGA barcode identifier for the study participant, eg TCGA-02-0001",
        "Letter code of the sample type using the TCGA standards, eg TPN, EBV. Full list available at https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/sample-type-codes",
        "Subclonal genome fractions; more information available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383288/",
        "Number of whole genome doublings",
        "Value based on the DNA content of the tumor cell population compared to normal diploid",
        "New' or 'old' calculations/solutions",
        "There are 10 sample types: Blood Derived Normal, Primary solid Tumor, Solid Tissue Normal, Recurrent Solid Tumor, Metastatic, Additional - New Primary, Primary Blood Derived Cancer - Peripheral Blood, Buccal Cell Normal, Additioanal Metastatic, Bone Marrrow Normal",
        "TCGA aliquot barcode, eg TCGA-12-1089-01A-01D-0517-28",
        " Average coverage necessary to obtain 80% power in 80% fraction of the genome"
    ],
    "sample_rows": [
        {
            "AliquotBarcode": "TCGA-AB-2879-03A-01D-0756-21",
            "ParticipantBarcode": "TCGA-AB-2879",
            "SampleBarcode": "TCGA-AB-2879-03A",
            "CallStatus": "called",
            "Purity": 0.25,
            "Ploidy": 2.0,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 43.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.0,
            "Solution": "new",
            "Study": "LAML",
            "SampleTypeLetterCode": "TB",
            "SampleType": "Primary Blood Derived Cancer - Peripheral Blood"
        },
        {
            "AliquotBarcode": "TCGA-ZC-AAAH-01A-11D-A427-01",
            "ParticipantBarcode": "TCGA-ZC-AAAH",
            "SampleBarcode": "TCGA-ZC-AAAH-01A",
            "CallStatus": "called",
            "Purity": 0.25,
            "Ploidy": 2.0,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 43.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.09,
            "Solution": "new",
            "Study": "THYM",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        },
        {
            "AliquotBarcode": "TCGA-44-3396-01A-01D-1204-01",
            "ParticipantBarcode": "TCGA-44-3396",
            "SampleBarcode": "TCGA-44-3396-01A",
            "CallStatus": "called",
            "Purity": 0.24,
            "Ploidy": 2.13,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 45.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.16,
            "Solution": "new",
            "Study": "LUAD",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        },
        {
            "AliquotBarcode": "TCGA-2K-A9WE-01A-11D-A381-01",
            "ParticipantBarcode": "TCGA-2K-A9WE",
            "SampleBarcode": "TCGA-2K-A9WE-01A",
            "CallStatus": "called",
            "Purity": 0.22,
            "Ploidy": 2.38,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 52.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.11,
            "Solution": "new",
            "Study": "KIRP",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        },
        {
            "AliquotBarcode": "TCGA-49-AAQV-01A-11D-A396-01",
            "ParticipantBarcode": "TCGA-49-AAQV",
            "SampleBarcode": "TCGA-49-AAQV-01A",
            "CallStatus": "called",
            "Purity": 0.25,
            "Ploidy": 1.94,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 41.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.43,
            "Solution": "new",
            "Study": "LUAD",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        }
    ]
}